ADVERTISEMENT

If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.

It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.

Wiley InterScience

< Previous Abstract  |  Next Abstract >

Save Article to My Profile      Download Citation      Request Permissions

Abstract |  References  |  Full Text: PDF (Size: 466K)  | Related Articles | Citation Tracking

Skin reactions to hydroxyzine
M. Michel 1 , A. Dompmartin 1 , S. Louvet 1 , C. Szczurko 1 , B. Castel 1 D. Leroy 1
  1 Department of Dermatology of Caen, France
Correspondence to  Dominique Leroy, Service de Dermatologie, Centre Hospitalier Universitaire, Avenue Georges Clemenceau, 14033 Caen, France. Tel: 02 31 27 25 06, Fax: 02 31 27 25 25
Copyright Munksgaard 1997
KEYWORDS
hydroxyzine • histamine H1-antagonists • antihistamine drug eruption • adverse drug reaction • lack of cross-sensitivity

ABSTRACT

Sensitivity to histamine H1-antagonists has mainly been observed with phenothiazine and ethylenediamine, and is very rare with hydroxyzine. We report 3 cases of sensitization to hydroxyzine, which was prescribed to treat urticaria and atopic dermatitis. A generalized maculopapular eruption appeared shortly after taking the drug. Patch tests with Atarax® tablet were positive +++, and ++ or +++ with different dilutions of hydroxyzine. Patch tests with ethylenediamine, piperazrne and other antihistamines were negative: therefore, there is no cross-allergy. We believe these rapid systemic reactions to hydroxyzine after the initial dose may have been due to prior systemic sensitivity to this drug, which cannot be used topically. Allergy to antihistamines must be considered when cutaneous lesions worsen on such therapy.


Accepted for publication 23 November 1996

DIGITAL OBJECT IDENTIFIER (DOI)
10.1111/j.1600-0536.1997.tb00397.x About DOI

Related Articles

  • Find other articles like this in Wiley InterScience
  • Find articles in Wiley InterScience written by any of the authors

Wiley InterScience is a member of CrossRef.

Cross Ref Member


Sign Up Now
Sign Up Now
Sign Up Now
Wiley Medical Twitter